iiinova — where your digital self keeps evolving

Shona Ritchie @shonaritchie.bsky.social · 07/10/2025

Had a fantastic time at @myueg.bsky.social week in Berlin, sharing science and meeting new colleagues/pals! Huge thanks to @metastasisresearch.bsky.social for making it possible for me to attend and share our research

083

Reposted by Shona Ritchie

MBSANZ @mbsanz.bsky.social · 26/03/2025

Congratulations to @mbsanz.bsky.social MCR Paper of the Year 2024 Recipients, Brooke Pereira & Shona Ritchie, (co-led by @tcox.bsky.social ), for their latest work looking at the role of Nidogen-2 in pancreatic cancer published in Science Advances! www.science.org/doi/10.1126/...

science.org

Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response

Temporal mass spectrometry proteomics, advanced microscopy, and in vivo modeling reveal nidogen-2 as a cotarget in PDAC.

084

Shona Ritchie @shonaritchie.bsky.social · 20/03/2025

🥳 So happy to share I’ve been awarded a Cancer Institute NSW Fellowship! This will support my work on investigating metabolic perturbations in pancreatic cancer with the Timpson Lab @garvaninstitute.bsky.social @cancerecogarvan.bsky.social

1101

Reposted by Shona Ritchie

Daniel Reed @daniel-reed.bsky.social · 14/03/2025

Excited to kick off my Bluesky posting by sharing this work by the lab looking at the role of neuropeptideY in #pancreaticcancer metastasis. An amazing piece of work and so thrilled to see it finally out! @garvaninstitute.bsky.social www.science.org/doi/10.1126/...

science.org

Targeting the NPY/NPY1R signaling axis in mutant p53–dependent pancreatic cancer impairs metastasis

Targeting NPY1R reduces mutant p53–dependent pancreatic cancer metastasis.

061